This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

Janssen COVID-19 Vaccine (Ad26.COV2.S)

Medical Information

Discontinuation and EUA Withdrawal

Last Updated: 05/06/2024

SUMMARY  

  • On May 22, 2023, Janssen requested the voluntary withdrawal of the emergency use authorization (EUA) of the Janssen COVID-19 Vaccine. On June 1, 2023, the Food and Drug Administration (FDA) revoked the EUA for this vaccine.1
  • The last lots of the vaccine purchased by the United States (U.S.) Government expired on May 13, 2023.   
  • The discontinuation and EUA withdrawal are not associated with concerns about the quality or safety of the Janssen COVID-19 Vaccine.
  • Any unused COVID-19 vaccine or waste material should be disposed in compliance with local guidance.
  • For inquiries about the status of Janssen COVID-19 Vaccine outside of the U.S., please visit https://www.janssen.com/covid-19-vaccine.
  • For additional information, please visit http://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/janssen-covid-19-vaccine.

 

References

1 Food and Drug Administration. Janssen COVID-19 Vaccine. 01 June 2023. Available at: https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/janssen-covid-19-vaccine.